Fredun Pharmaceuticals
add_icon

Fredun Pharmaceuticals

1,619.70
-1,619.70
(-100.00%)
Market Cap
869.10 Cr
PE Ratio
26.60
Volume
0.00
Day High - Low
1,650.00 - 1,551.50
52W High-Low
1,999.00 - 635.05
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
869.10 Cr
EPS
33.66
PE Ratio
26.60
PB Ratio
3.66
Book Value
443.15
EBITDA
38.90
Dividend Yield
0.04 %
Industry
Healthcare
Return on Equity
12.86
Debt to Equity
0.88
Forecast For
Actual

Company News

View All News
Caret
neutral
Fredun Pharmaceuticals Limited announces investor meeting on March 18, 2026 in Mumbai to discuss business overview and financial performance, organized by Share India Securities Limited.
positive
Infomerics upgrades Fredun Pharmaceuticals' credit rating to IVR BBB+ (Stable) from IVR BBB for bank facilities worth ₹156.17 crore, reflecting improved operational performance and financial strength.
positive
Fredun Pharmaceuticals Limited successfully conducted its Extra-Ordinary General Meeting on February 16, 2026, via video conferencing with 42 shareholders attending and unanimously approving the appointment of Mrs. Pooja Narendra Sanghavi as Non-Executive Independent Director.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,744.40
#1 4,18,540.00
38.21
#1 54,729.00
9.71
#1 10,980
16.07
46.21
5,972.50
1,58,551.10
64.01
9,712.00
18.67
2,191
-1.02
35.70
4,210.80
1,42,512.60
62.70
11,539.40
6.99
1,911
26.24
44.98
1,274.50
1,06,373.60
19.25
33,741.20
16.73
5,725
-15.28
47.17
2,251.50
1,02,848.30
22.06
22,909.50
13.74
3,306
#1 37.44
45.75
1,239.20
1,00,099.10
22.07
28,409.50
7.12
5,291
-57.18
24.80
876.15
88,161.20
#1 17.54
23,511.00
18.55
4,615
-0.32
40.05
2,000.80
82,594.00
45.82
12,744.20
#1 20.90
2,007
7.65
37.28
1,247.50
72,455.00
20.80
32,345.60
9.43
3,484
7.59
53.16
5,240.00
62,652.10
25.87
13,458.30
3.70
2,216
1.90
36.58
Growth Rate
Revenue Growth
26.26 %
Net Income Growth
44.44 %
Cash Flow Change
96.95 %
ROE
14.72 %
ROCE
9.48 %
EBITDA Margin (Avg.)
4.01 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
0
0
286
165
119
144
160
Expenses
0
0
251
150
103
123
135
EBITDA
0
0
35
15
17
21
25
Operating Profit %
0 %
0 %
12 %
9 %
14 %
14 %
16 %
Depreciation
0
0
3
2
1
2
2
Interest
0
0
14
8
7
8
11
Profit Before Tax
0
0
20
7
9
13
14
Tax
0
0
7
1
2
3
4
Net Profit
0
0
14
6
7
9
11
EPS in ₹
0.00
0.00
29.09
12.71
14.33
19.98
22.19

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
23
43
56
79
105
141
162
187
257
308
Fixed Assets
8
15
16
16
31
31
30
32
39
47
Current Assets
13
28
35
52
73
109
130
153
216
257
Capital Work in Progress
1
0
4
11
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
1
Other Assets
14
29
36
52
74
110
131
155
218
260
Total Equity & Liabilities
23
43
56
79
105
141
162
187
257
308
Current Liabilities
16
32
41
43
53
86
87
74
140
167
Non Current Liabilities
4
7
8
14
13
14
32
45
21
19
Total Equity
3
4
7
22
39
41
43
68
96
122
Reserve & Surplus
1
1
2
19
35
37
39
63
84
115
Share Capital
3
3
5
3
4
4
4
4
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
1
-1
1
0
2
-2
1
1
-2
Investing Activities
-3
-6
-7
-8
-5
-2
-1
-4
-9
-8
Operating Activities
2
3
4
17
1
-11
0
-2
-14
-0
Financing Activities
1
4
3
-8
4
14
-1
8
25
6

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
May 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Feb 2026
Promoter
52.04 %
52.04 %
52.04 %
51.27 %
51.27 %
51.27 %
51.04 %
51.04 %
50.34 %
50.15 %
49.62 %
49.62 %
49.33 %
49.31 %
49.16 %
49.17 %
48.92 %
49.17 %
48.93 %
48.93 %
48.93 %
48.93 %
48.93 %
43.06 %
43.06 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.46 %
1.06 %
DIIs
1.88 %
1.88 %
1.88 %
1.69 %
1.69 %
1.69 %
1.68 %
1.68 %
1.66 %
1.65 %
1.64 %
1.64 %
1.61 %
1.60 %
1.60 %
1.60 %
1.59 %
1.60 %
1.59 %
1.59 %
1.59 %
1.59 %
1.60 %
3.48 %
2.89 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
41.01 %
40.99 %
40.77 %
41.56 %
41.90 %
41.81 %
42.02 %
42.08 %
42.48 %
43.07 %
43.64 %
43.60 %
43.48 %
43.49 %
43.67 %
44.02 %
43.94 %
43.89 %
44.21 %
44.55 %
44.50 %
44.52 %
43.74 %
45.18 %
45.63 %
Others
5.07 %
5.09 %
5.32 %
5.47 %
5.13 %
5.23 %
5.25 %
5.19 %
5.52 %
5.13 %
5.10 %
5.14 %
5.58 %
5.60 %
5.58 %
5.22 %
5.55 %
5.35 %
5.27 %
4.93 %
4.98 %
4.96 %
5.72 %
7.83 %
7.37 %
No of Share Holders
0
1,993
2,301
3,681
3,674
3,573
3,620
3,678
3,901
4,521
4,609
4,625
4,627
4,635
6,315
7,507
6,840
7,511
8,018
8,121
7,976
7,906
8,120
8,749
8,443

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.6 1 0.65 0.66 0.7 0.7 0.7 0.7 0.00 0.00
Dividend Yield (%) 0.42 0.24 0.56 0.14 0.08 0.09 0.1 0.1 0.00 0.00

Announcements

Announcement under Regulation 30 (LODR)-Meeting Updates3 days ago
Analyst/Institutional Investors Meeting Held On Wednesday 11Th March 2026 Organised By Arihant Capital - Bharat Connect Conference Rising Star 2026.7 days ago
Intimation Of Schedule Of Bharat Connect Conference Under The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 05, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 25, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 25, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 16, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 16, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMFeb 16, 2026
Statement Of Deviation Or Variation For The Quarter Ended December 31 2025Feb 14, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 14, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday February 14 2026 At 05:00 P.M Through Video Conferencing (VC)Feb 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026
Revised OutcomeFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 09, 2026
Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2025Feb 09, 2026
Board Meeting Outcome for Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2025Feb 09, 2026
Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Monday 09Th February 2026Jan 30, 2026
Notice Of Book Closure For The Purpose Of Extra Ordinary General Meeting (EGM)Jan 20, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 20, 2026
Notice Convening Extra-Ordinary General Meeting (EGM) Of Fredun Pharmaceuticals LimitedJan 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Closure of Trading WindowDec 31, 2025
Announcement under Regulation 30 (LODR)-AllotmentDec 29, 2025
Announcement under Regulation 30 (LODR)-AllotmentDec 29, 2025
Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Allottees Ultimate Beneficial Owners (Ubos) Revised Issue Size Of Proposed Preferential Allotment Revised List Of Allottees And Bifurcation And BrieDec 18, 2025
Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Allottees Ultimate Beneficial Owners (Ubos) Revised Issue Size Of Proposed Preferential Allotment Revised List Of Allottees And Bifurcation And BrieDec 18, 2025
Intimation Of Outcome Of Analysts/Investors Meeting Under The SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015Dec 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 11, 2025
Corrigendum Through General Announcement Regarding Disclosure Of Ultimate Beneficial Owners (Ubos) Pre -Preferential Shareholding Of Proposed Allottees And Bifurcation And Brief Description Of The Object In Connection With The Extra-Ordinary General MeetiNov 29, 2025
Appointment of Company Secretary and Compliance OfficerNov 28, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateNov 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 28, 2025
General Announcement Pertaining To Disclosure Of Ultimate Beneficial Owners (Ubos) Of Proposed Allottees In Connection With The Extra-Ordinary General Meeting (EGM) Held On October 22 2025.Nov 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 14, 2025
Audio Recording Of The Q2 FY26 Earnings Conference CallNov 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 10, 2025
Revised Outcome Of Board MeetingNov 09, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerNov 08, 2025
Outcome Of Board MeetingNov 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting.Nov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2025
Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Saturday 08Th November 2025Oct 28, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 22, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMOct 22, 2025
Corrigendum I To The Notice Of Extraordinary General Meeting.Oct 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 13, 2025

Technical Indicators

RSI(14)
Neutral
47.42
ATR(14)
Less Volatile
101.16
STOCH(9,6)
Neutral
49.05
STOCH RSI(14)
Neutral
60.42
MACD(12,26)
Bearish
-0.70
ADX(14)
Weak Trend
19.49
UO(9)
Bearish
46.44
ROC(12)
Downtrend And Accelerating
-0.58
WillR(14)
Neutral
-58.08